Abstract

ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient

Author(s): Moon Richard B

Issue: Mar/Apr 2006 - Hospice/Palliative Care

Page(s): 95-98

Download in electronic PDF format for $75
  • ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Page 1
  • ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Page 2
  • ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Page 3
  • ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Page 4

Abstract

Hospice patients at the end stages of life often suffer nausea and vomiting, distressing symptoms that are either side effects of medications or direct effects of the underlying disease state. Such symptoms can greatly diminish the hospice patient’s quality of life. Effective pharmacotherapy is available, but in many cases traditional dosage forms are incompatible with the patient’s physical condition, cause discomfort, or are difficult for family members to administer. In such cases, a compounded preparation containing lorazepam, diphenhydramine, haloperidol, and metoclopramide—commonly referred to as ABHR gel—has proven highly effective. A number of case reports are presented to illustrate the effectiveness of ABHR gel in relieving the symptoms of nausea and vomiting in hospice patients. Also discussed are the causes of vomiting and the mechanisms of each of the medications contained in the ABHR gel.

Related Keywords

  • hospice
  • palliative care
  • palliation
  • symptoms
  • nausea
  • vomiting
  • antiemetics
  • ABHR gel
  • lorazepam
  • diphenhydramine
  • haloperidol
  • metoclopramide
  • transdermal administration
  • topical preparation
  • combination therapy

Related Categories

  • GASTROENTEROLOGY
  • HOSPICE/PALLIATIVE CARE
  • MENTAL HEALTH
  • CASE REPORTS
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2006
Pg. 95-98
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Author(s): Moon Richard B
Jul/Aug 2000
Pg. 250-251
Nausea and Vomiting in Hospice Patients
Author(s): Boomsma Diane
Mar/Apr 2020
Pg. 168-175
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
May/Jun 2014
Pg. 190-200
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice
Author(s): McNulty John P, Muller George
Jul/Aug 2006
Pg. 288-290
Hospice Symptom Relief Kit: An Update
Author(s): Petrin Ronald L
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Mar/Apr 2006
Pg. 147-153
Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis
Author(s): Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn
May/Jun 2003
Pg. 183
ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl)
Author(s): Allen Loyd V Jr
Mar/Apr 2013
Pg. 113-123
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Author(s): Zur Eyal
Mar/Apr 2006
Pg. 89-93
Hospice from a Compounding Pharmacist's Perspective
Author(s): Jones Marty
Jan/Feb 2008
Pg. 28-37
Hospice and Compounding Pharmacy: Once Inseperable
Author(s): Williams LaVonn A
May/Jun 2009
Pg. 220-221
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report
Author(s): Muller George
Mar/Apr 1998
Pg. 116-117
The Symptom Relief Kit for Hospice Patients
Author(s): Petrin Ronald L
Jul/Aug 2024
Pg. 278-281
Ketamine for Pain in Hospice Patients - A Transdermal Gel Applied to the Painful Site
Author(s): Wood Robert M
Jul/Aug 2000
Pg. 255-256
Custom-Making Medications for the Hospice Patient
Author(s): Horwitz Robert
Jul/Aug 2000
Pg. 297
Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO
Author(s): Allen Loyd V Jr
Nov/Dec 2011
Pg. 504
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 247-253
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Jul/Aug 2000
Pg. 253-254
Ketamine for Pain in Hospice Patients
Author(s): Wood Robert M
Jul/Aug 2000
Pg. 246-249
Hospice and the Role of the Compounding Pharmacist
Author(s): Carling Maureen A